Peptic Ulcers drugs in development, 2023

GlobalData tracks 28 drugs in development for Peptic Ulcers by 27 companies/universities/institutes. The top development phase for Peptic Ulcers is phase i, with 11 drugs in that stage.

Stanford researchers uncover key to overcoming chemoresistance in pancreatic cancer

Pancreatic cancer is a particularly aggressive and difficult-to-treat cancer, in part because it is often resistant to chemotherapy.

July 5, 2024

Schizophrenia drug AbbVie picked up in $9 billion acquisition fails in key trials

AbbVie said Monday that its experimental treatment for schizophrenia failed to significantly help patients in two trials, a blow to the company, which got the

November 11, 2024

A promising approach for aging research

In mid-January 2024, the Friedrich Schiller University Jena made an important discovery public: A team of researchers from the universities of Jena and Shenzhen (China),

February 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.